|
⚲
|
| Keyboard |
| Arrivent Biopharma Inc | |
|---|---|
| Ticker | AVBP |
| CIK # | 0001868279 |
| CUSIP | 04272N102 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 18 Campus Blvd Suite 100, Newtown Square, PA 19073-3269 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Arrivent Biopharma Inc | 2022-12-29 | 110.0 M | Exemption: 506(b) · Remaining: $35,000,011 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001868279] | 10-K | |
| [0001868279] | 10-Q | |
| [0001868279] | 3 | |
| [0001868279] | 4 | |
| [0001868279] | 8-K | |
| [0001868279] | D | |
| [0001868279] | SC 13D | |
| [0001868279] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
LaChapelle Robin
Stock Option (right to buy) · derivative
|
2026-02-02 | Grant | 130,000 | $0.00 | |
|
Lutzker Stuart
Stock Option (right to buy) · derivative
|
2026-02-02 | Grant | 150,000 | $0.00 | |
|
Kung Winston
Stock Option (right to buy) · derivative
|
2026-02-02 | Grant | 140,000 | $0.00 | |
|
Yao Zhengbin
Stock Option (right to buy) · derivative
|
2026-02-02 | Grant | 550,000 | $0.00 | |
|
Kastenmayer James Paul
Stock Option (right to buy) · derivative
|
2026-02-02 | Grant | 130,000 | $0.00 | |
|
HHLR Advisors Ltd +1
Common Stock
|
2025-12-10 | Sell | 555,555 | $23.37 | 12,983,320 |
|
LaChapelle Robin
Common Stock
|
2025-07-11 | Option exercise | 2,600 | $2.28 | 5,928 |
|
LaChapelle Robin
Common Stock
|
2025-07-11 | Option exercise | 2,050 | $2.28 | 4,674 |
|
LaChapelle Robin
Common Stock
|
2025-07-11 | Option exercise | 6,503 | $2.28 | 14,827 |
|
LaChapelle Robin
Stock Option (right to buy) · derivative
|
2025-07-11 | Option exercise | 2,600 | $0.00 | |
|
LaChapelle Robin
Stock Option (right to buy) · derivative
|
2025-07-11 | Option exercise | 6,503 | $0.00 | |
|
LaChapelle Robin
Stock Option (right to buy) · derivative
|
2025-07-11 | Option exercise | 2,050 | $0.00 | |
|
Parsey Merdad
Non-Qualified Stock Option (right to buy) · derivative
|
2025-06-18 | Grant | 15,502 | $0.00 | |
|
Peterson Kristine
Non-Qualified Stock Option (right to buy) · derivative
|
2025-06-18 | Grant | 15,502 | $0.00 | |
|
Hohneker John
Non-Qualified Stock Option (right to buy) · derivative
|
2025-06-18 | Grant | 15,502 | $0.00 | |
|
Nolet Chris
Non-Qualified Stock Option (right to buy) · derivative
|
2025-06-18 | Grant | 15,502 | $0.00 | |
|
Parsey Merdad
Stock Option (right to buy) · derivative
|
2025-04-28 | Grant | 28,346 | $0.00 | |
|
Yao Zhengbin
Stock Option (right to buy) · derivative
|
2025-02-03 | Grant | 380,000 | $0.00 | |
|
Lutzker Stuart
Stock Option (right to buy) · derivative
|
2025-02-03 | Grant | 120,000 | $0.00 | |
|
LaChapelle Robin
Stock Option (right to buy) · derivative
|
2025-02-03 | Grant | 120,000 | $0.00 | |
| showing 20 of 64 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 140 | 42,604,451 |
| 2025-12-31 | 124 | 40,392,083 |
| 2025-09-30 | 107 | 38,681,134 |
| 2025-06-30 | 99 | 33,593,715 |
| 2025-03-31 | 84 | 29,075,131 |
| 2024-12-31 | 81 | 28,465,888 |
| 2024-09-30 | 69 | 25,922,059 |
| 2024-06-30 | 55 | 21,658,375 |
| 2024-03-31 | 54 | 21,906,782 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| TEMA ETFS LLC | [2026-06-30] | SOLE | 57,034 | 57,034 |
| Moody Aldrich Partners LLC | [2026-06-30] | SOLE | 19,140 | 44,044 |
| Ellsworth Advisors LLC | [2026-06-30] | SOLE | 0 | 27,001 |
| Y-Intercept Hong Kong Ltd | [2026-06-30] | SOLE | 11,843 | 11,843 |
| PSP Research LLC | [2026-06-30] | SOLE | 0 | 7,041 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 631 |
| Gamma Investing LLC | [2026-06-30] | DFND | 435 | 435 |
| Versant Capital Management Inc | [2026-06-30] | SOLE | 423 | 423 |
| Torren Management LLC | [2026-06-30] | SOLE | 0 | 33 |
| MassMutual Private Wealth & Trust FSB | [2026-06-30] | SOLE | 22 | 22 | Prev | Page 1 | Next |